Where does JCR Pharmaceuticals Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), JCR Pharmaceuticals Co., Ltd. ranks #8,056 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does JCR Pharmaceuticals Co., Ltd. hold?

JCR Pharmaceuticals Co., Ltd. holds 40 US utility patents granted between 2016 and 2025, spanning 19 technology areas.

What is JCR Pharmaceuticals Co., Ltd.'s Innovation Score?

JCR Pharmaceuticals Co., Ltd. has an Innovation Score of 43.4 out of 100 (top 28% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is JCR Pharmaceuticals Co., Ltd.'s patent grant rate increasing or decreasing?

JCR Pharmaceuticals Co., Ltd.'s recent grant velocity is +79% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for JCR Pharmaceuticals Co., Ltd.'s patents?

JCR Pharmaceuticals Co., Ltd.'s patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the JCR Pharmaceuticals Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

JCR Pharmaceuticals Co., Ltd.

Q: What technology areas does JCR Pharmaceuticals Co., Ltd. focus on?

JCR Pharmaceuticals Co., Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 26 patents, ranking #417 of 4,144 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

USPTO PatentsView assignee record - 40 granted patents across 19 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, JCR ranks #8,056 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 19 technology areas.

#8,056
of 49,997 US assignees by volume: Top 28%
by Innovation Score (43.4/100): 16.2
avg claims per patent: +79%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8056 · Foreign Corporation #8,056 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #8,056/49,997
PHOTO-FINISH IngenioSpec
CPC-FOCUS C12N · 19 areas
INNOV-PAR 43.4/100
CLAIMS-RICH 16.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +79% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: IngenioSpec, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How JCR’s 43.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (30%) Velocity 5.4 pts (12%) Breadth 15.4 pts (36%) Claim depth 9.7 pts (22%)

Qualcomm Incorporated · highest

85
Bauer Spezialtiefbau · near

43
CommScope Italy S R L · near

43
Gemtek Technology · near

43
Hindustan Petroleum · near

43
JCR Pharmaceuticals · this assignee

43
3D Lighting… · lowest

7

What this shows JCR's Innovation Score is 43.4/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for JCR?

Each dot is one of JCR’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). JCR’s own 16.2 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

JCR vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where JCR's grants concentrate

JCR Pharmaceuticals Co., Ltd. is a focused PatentsView assignee: 19 CPC subclasses with 65% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (7 grants) versus a trough of 2 in 2016. By volume, JCR sits between IngenioSpec, LLC and Keihin Thermal Technology Corporation.

JCR's three-year grant acceleration

JCR Pharmaceuticals Co., Ltd. shows 13 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ingeniospec

40
Invent ly

40
Ivani

40
J W Speaker

40
Jetzero

40
Johannes Gutenber…

40
John Zink

40
Keihin Thermal Te…

40
JCR Pharmaceutica… ◀

40

What this shows JCR holds 40 patents at rank #8,056, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near JCR

By rank, the assignees closest to #8,056 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in JCR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for JCR, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), JCR ranks #417 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Gemtek Technology Co., Ltd. 43 Hindustan Petroleum Corporation Limited 43 Bauer Spezialtiefbau GmbH 43 CommScope Italy S.R.L. 43

JCR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 28% higher than 72% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

JCR Pharmaceuticals Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	5.0%
2017	4	10.0%
2018	4	10.0%
2019	4	10.0%
2020	6	15.0%
2021	6	15.0%
2022	2	5.0%
2023	4	10.0%
2024	7	17.5%
2025partial year	1	2.5%

Which technologies does JCR Pharmaceuticals Co., Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 26

C07K - Peptides 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 20

C12Y - Enzymes 11

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

B01D - Separation 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C07C - Acyclic OR Carbocyclic Compounds 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

JCR Pharmaceuticals Co., Ltd.'s patent record in context - here's where to go next.

JCR Pharmaceuticals Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 65% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #8,056 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare JCR Pharmaceuticals Co., Ltd. against IngenioSpec, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.